Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.
One hope to maintain the benefits of antiviral therapy against the human immunodeficiency virus type 1 (HIV-1), despite the development of resistance, is the possibility that resistant variants will show decreased viral fitness. To study this possibility, HIV-1 variants showing high-level resistance...
Kaydedildi:
| Yayımlandı: | J Virol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1997
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191160/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8995629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.2.1089-1096.1997 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|